US4635641A - Multi-element electrode - Google Patents

Multi-element electrode Download PDF

Info

Publication number
US4635641A
US4635641A US06/788,215 US78821585A US4635641A US 4635641 A US4635641 A US 4635641A US 78821585 A US78821585 A US 78821585A US 4635641 A US4635641 A US 4635641A
Authority
US
United States
Prior art keywords
electrode
patch
treatment
adhesive
patches
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/788,215
Inventor
Kent C. Hoffman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Murray Electronics Associates LP
Original Assignee
Murray Electronics Associates LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Murray Electronics Associates LP filed Critical Murray Electronics Associates LP
Priority to US06/788,215 priority Critical patent/US4635641A/en
Assigned to MURRAY ELECTRONICS ASSOCIATES LIMITED PARTNERSHIP, 260 SCHILLING CIRCLE, HUNT VALLEY, MD., 21030, reassignment MURRAY ELECTRONICS ASSOCIATES LIMITED PARTNERSHIP, 260 SCHILLING CIRCLE, HUNT VALLEY, MD., 21030, ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: HOFFMAN, KENT C.
Application granted granted Critical
Publication of US4635641A publication Critical patent/US4635641A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0472Structure-related aspects
    • A61N1/0492Patch electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0452Specially adapted for transcutaneous muscle stimulation [TMS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0456Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0468Specially adapted for promoting wound healing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0472Structure-related aspects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0472Structure-related aspects
    • A61N1/0476Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)

Definitions

  • This invention is generally directed to a multi-element body electrode for therapeutic and diagnostic applications in medical and veterinary use.
  • the subject invention is related to the copending and commonly assigned applications Ser. No. 711,044, filed Mar. 12, 1985, Ser. No. 783,093 filed Oct. 2, 1985 and Ser. No. 788,216 filed Oct. 16, 1985, the entire disclosures of which are hereby incorporated by reference.
  • Electrodes Numerous types of electrodes have been used in the medical field, for both diagnostic applications such as EKG, EMG and EEG and therapeutic applications such as electrical muscle stimulators, transcutaneous electrical nerve stimulators and iontophoresis drug delivery stimulators.
  • diagnostic applications such as EKG, EMG and EEG
  • therapeutic applications such as electrical muscle stimulators, transcutaneous electrical nerve stimulators and iontophoresis drug delivery stimulators.
  • the need to place electrodes at the correct locations has long been recognized as important as well as the need to use electrodes of a correct size.
  • the requirements for correct placement and correct size become even more important for electrical signals that are monophasic or asymmetrical in shape.
  • Two or more electrodes of the same or varying sizes are individually placed on the patient undergoing some form of electrotherapy or diagnostic procedure. In many cases, optimum results are not obtained because the electrodes are not placed on the subject in the correct fashion.
  • U.S. Pat. No. 3,848,608 discloses a cutaneous stimulator which includes a plurality of pairs of electrodes and ventilation holes located in a ground plane between each adjacent pair of electrodes. This stimulator does not provide an arrangement of electrodes relative to the holes such that therapeutic current density is particularly determined in the vicinity of the holes. Further the arrangement disclosed in this reference does not necessarily provide electrode location control or easy access to the injury being treated.
  • the exemplary embodiment of this invention provides two or more spaced-apart conductive patches with an adhesive boundary extending at least part way about the edges of the patches.
  • the adhesive boundary may comprise a relatively larger adhesive-backed, flexible insulating sheet patch with the relatively smaller conductive patches being affixed therewithin at predetermined proper relative locations (on the one adhesive-coated side).
  • the adhesive-coated border around at least a portion of the electrodes (and preferably completely thereabout) permits the electrodes to be adhesively affixed to treatment locations where electrodes cannot easily be affixed by traditional wrapping techniques.
  • Such an adhesive border forms an occlusive seal with hair, fur and external body tissue surfaces at a time when the treatment site is still relatively clean and dry.
  • the insulating sheet has at least one aperture therein so as to provide access aperture(s) to the treatment site.
  • a release liner is also preferably included and is releasably attached to and covering the otherwise exposed adhesive-backing of the insulating sheet prior to its intended usage.
  • Such a release liner typically is formed of two parts so that the flexible electrode assembly can be slightly flexed to permit easy fingertip access to an edges of the liner thus facilitating its easy removal just prior to the time of intended usage.
  • Electrical snap-on connection terminals are preferably affixed to each conductive patch and extend backwards through a further aperture in the insulating sheet so as to permit ready electrical connection of a suitable electrical lead from an electrical signal generator or other conventional treatment/diagnostic apparatus.
  • the conductive patches of the assembly are preferably flexible and may be formed from thin metal foil patches pre-laminated to their own thin insulating coating so as to provide added structural strength and to facilitate adhesion to the adhesive-backed insulating patch.
  • FIG. 1 is an exploded perspective view of the various components used in an exemplary embodiment of the adhesively applied multi-element electrode of this invention
  • FIG. 2 is a cross-sectional view of the assembled electrode of FIG. 1;
  • FIGS. 3 and 4 are perspective and cross-sectional views of the FIGS. 1 and 2 embodiment in place with the external body surface of a living subject;
  • FIGS. 5-9 are perspective views of other exemplary embodiments of the invention.
  • FIGS. 10 and 11 are plan views of two further exemplary embodiments of the electrode structure.
  • This invention relates to multiple element electrodes that have predetermined relative sizes and locations relative to an aperture in a common substrate which is applied as a single unit, with the aperture conveniently being used to (1) properly locate the electrodes vis-a-vis the desired treatment site and (2) provide access to the treatment site after affixation of the electrode structure.
  • the electrode elements are constructed of a metal foil or film such as aluminum or a conductive film such as silver paint or carbon compound paint. These elements are affixed to an adhesive coated, thin, clear film such as pvc or mylar or are screened on a thin, clear film with adhesive selectively screened on at the same time.
  • the multi-element electrode is produced with an opening or treatment site window to identify correct placement of the multi-electrode unit over the wound or injury.
  • a release liner is provided on the back of the electrode.
  • a two element example of this multi-element electrode that is useful for treating small skin wounds or burns is shown in FIG. 1.
  • a monophasic or asymmetrical wave may be conventionally applied across the two elements correctly by use of different size electrical connectors or snaps that mate with the corresponding wires from a stimulator.
  • An important feature of this invention is that one element, identified as the treatment electrode, is maintained at a fixed and optimum distance from the other remote electrode element(s) and at the same time is maintained at a close, but fixed optimum distance from the injury by means of properly locating the treatment site window over the treatment site. Also typically important in such situations is the fact that the surface area of the treatment electrode may be smaller than the surface area of the remote electrode(s) and that a fixed size ratio and relative location is maintained between electrode elements by use of this multi-element electrode. The current density at the injury or treatment site is maintained at a correct higher therapeutic level while the current density under the remote electrode(s) is lower due to the larger surface area of the remote electrode(s).
  • the resulting current density (e.g., amperes per square centimeter) is a function of I/A.
  • the current density can be increased by making the electrode of smaller size or, vice versa, it can be decreased by making the electrode of larger size.
  • the distance of a given tissue mass from an electrode and its relative location with respect to the anode-cathode current path) will also affect the actual current density through the tissue mass (e.g., a wound). In this fashion, the relative sizes and placements of anode and cathode electrodes can be used to determine the effective current density through a wound.
  • an electrode 103 of relatively large area as shown in FIG. 1 is utilized as an anode while a relatively smaller electrode 102 is applied relatively closer to a desired treatment site marker hole 116 (so as to provide an increased physiologically significant electrical current density thereabout) as a cathode electrode, and connected to the signal source (not shown) by lead wire 50. Electrical signals are then conventionally applied to the electrodes so as to achieve desired treatment effects.
  • the smaller electrode 102 is the anode, and thus the electrode 103 is the cathode.
  • some signal sources e.g. transcutaneous nerve stimulators (TENS), supply biphasic signals to the electrodes, i.e. alternating current or waveforms with both positive and negative components.
  • TENS transcutaneous nerve stimulators
  • the present invention can be used with a biphasic signal having the smaller electrode 102 relatively close to the treatment site and the larger electrode 103 at a more remote location. This arrangement insures a higher density at the treatment site and a lower, non-biologically stimulative, signal at the larger electrode 103.
  • Multi-element electrode 100 is shown in detail at FIGS. 1 and 2.
  • Conductive metal foils 102 and 103 constitute the active electrode surfaces.
  • foils 102 and 103 are each actually a very thin (e.g., 0.00035 inch) layer of aluminum foil pre-laminated to a very thin (e.g., 0.00092) layer of polyester film (laminated to the top of structure 102 as seen in FIG.
  • the laminated aluminum foil/polyester films 102 and 103 may be cut from commerically available material (e.g. part No. 1035 from Lam-A-Shield Incorporated, Cleveland, Ohio).
  • the presently preferred adhesive-backed patch 104 is also cut from commerically available material (e.g. part No. 7350 from 3M Corporation which comprises a thin (e.g., 0.002 inch) insulating sheet of polypropylene with a thin (e.g., 0.0008 inch) coating of acrylic adhesive 104 on one side).
  • a conventional snap-on type electrical connector comprising mated parts 106a and 106b is attached to a folded-over tab portion 108 of the laminated aluminum foil structure 102. Similar parts 107a and 107b are attached to the fold-over tab portion 109 of foil 103. Since it is folded over (as indicated by arrow 110), a conductive aluminum foil surface is exposed on both the top and bottom of the thus double thickness tab portions 108 and 109 for increased structural support and electrical area connection with the snap-on devices 106a and 106b and 107a and 107b.
  • the snap-on connector parts have a connector projection which extends backwardly (i.e. upwardly in FIG. 1) through apertures 112 and 113 respectively in the insulating patch 104 so as to be readily available for snap-on electrical connection to lead wires 50 and 51.
  • the flexible electrode assembly of FIGS. 1-2 also includes a releasable liner layer 122 which is normally in place covering the otherwise exposed portions of the adhesive surface 104a until the intended time of usage.
  • the release liner 122 will include a break 124 so that the entire assembly may be slightly bent at the break to gain finger access to a free edge of the releasable liner 122 and thus facilitate its strippage from the adhesive layer 104a and ready the assembly for adhesive affixation to the desired body surface area.
  • Release liner 122 is shown as including apertures 126, 128 and 129. Apertures 128 and 129 typically occurs because the liner 122 already may be in place when aperture 116 is cut during manufacturing processes and apertures 128 and 129 permit the assembly of snap-on connectors while the release liner 122 remains in place thus protecting the adhesive layer 104a during manufacturing processes. However it will be appreciated that such apertures are not required since the release liner 122 is typically removed before the remainder of the electrode assembly shown in FIGS. 1-2 is adhesively affixed to a desired body surface site and used.
  • FIG. 3 depicts the electrodes of FIGS. 1-2 with the releasable liner 122 removed and the remainder of the assembly adhesively secured in place to a desired external body surface 20a of a living subject.
  • the treatment site 20a should be clean and the connector end of cables 50 and 51 may be snapped onto the snap connectors 106a and 107a to installation of the electrode patches onto the treatment site.
  • the protective releasable liner 122 has been removed so as to expose a boundary 130 of adhesive 104a, the assembly is positioned with the treatment aperture 116 over the injury site 20b and pressed firmly thereto so as to assure a good adhesive bond. As shown in the cross-sectional view of FIG.
  • the boundary areas 130 will include an adhesively sealed and occluded area 130a which incorporates any contiguous body hair (or fur) so as to provide a substantially impervious seal between the external surface of living body 20 and the periphery of the conductive electrodes 102 and 103.
  • an electrode patch e.g. 203 can have an aperture 114 extending therethrough for receiving an electrode gel preparation material in the space located between the electrode patch and the skin surface, after the electrode patch is adhesively affixed to the skin.
  • the present invention may incorporate more than two electrodes, that is a treatment electrode and multiple remote electrodes (see FIGS. 6-8). Further, the electrodes may be arranged in a variety of ways and may be of various shapes and sizes. (see FIGS. 6-9). As shown in FIGS. 6-11, electrodes are denoted by numerals 302, 303; 402, 403; 502, 503; 602, 603; 702, 703; and 802, 803.
  • the flexible insulating substrate is generally shown by the out or most boundary lines and is denoted by reference numerals 704 and 804 in FIGS. 10 and 11 respectively.
  • FIG. 11 depicts an alternate embodiment without a continuous adhesive border.
  • each conductive patch may also be formed by printing, painting or otherwise placing conductive ink on a suitable substrate.
  • aluminum foil is preferred (e.g., it is conceivable that the ions which make an ink conductive might, over time, migrate under influence of the electrical treatment fields away from the printed ink itself thus deteriorating the overall electrode function).
  • the conductive patch 103 may be approximately 3 inches by 1 inch and the treatment electrode 102 about one inch square, while the insulating patch 104 may be approximately 5 ⁇ 51/2 inches in overall dimension.
  • Aperture 116 in the embodiment of FIGS. 1-2 may be approximately 0.688 inch diameter.
  • electrode apparatus and method described may also be utilized to achieve conductive coupling to the external skin surfaces of human subjects as well as animals.

Abstract

A multi-element body electrode for applying an electric signal to the skin and tissue of a living subject is disclosed. The apparatus comprises at least two metal film electrode elements affixed to an adhesive coated thin clear plastic film which extends beyond the edges of the electrodes to hold the electrodes in place on the skin. Between the electrodes is an opening which permits proper placement of the electrodes relative to the injury, and permits access to the injury.

Description

This invention is generally directed to a multi-element body electrode for therapeutic and diagnostic applications in medical and veterinary use. The subject invention is related to the copending and commonly assigned applications Ser. No. 711,044, filed Mar. 12, 1985, Ser. No. 783,093 filed Oct. 2, 1985 and Ser. No. 788,216 filed Oct. 16, 1985, the entire disclosures of which are hereby incorporated by reference.
BACKGROUND OF THE INVENTION
Numerous types of electrodes have been used in the medical field, for both diagnostic applications such as EKG, EMG and EEG and therapeutic applications such as electrical muscle stimulators, transcutaneous electrical nerve stimulators and iontophoresis drug delivery stimulators. The need to place electrodes at the correct locations has long been recognized as important as well as the need to use electrodes of a correct size. The requirements for correct placement and correct size become even more important for electrical signals that are monophasic or asymmetrical in shape. Two or more electrodes of the same or varying sizes are individually placed on the patient undergoing some form of electrotherapy or diagnostic procedure. In many cases, optimum results are not obtained because the electrodes are not placed on the subject in the correct fashion.
It is often necessary to establish a localized electrical contact with the external body surface of a living subject. Such contact is typically achieved by the use of electrically conductive electrodes having extended surface areas placed in electrical contact with a desired portion of an external body surface through an intermediate electrode gel, liquid or other preparation designed to ensure good and continuous electrical contact between the living body surface and the conductive electrode surface. Such electrical connections to living subjects are now commonly required for therapeutic and diagnostic applications in both medical and veterinary usage. For example, electro-therapeutic stimulation has now been recognized to promote the healing of bones and other body tissues and/or to have other advantageous physiological effects. Many diagnostic techniques (e.g., electrocardiograms) also require electrical connections to body surfaces so as to monitor electrical body surface potentials.
U.S. Pat. No. 3,848,608 discloses a cutaneous stimulator which includes a plurality of pairs of electrodes and ventilation holes located in a ground plane between each adjacent pair of electrodes. This stimulator does not provide an arrangement of electrodes relative to the holes such that therapeutic current density is particularly determined in the vicinity of the holes. Further the arrangement disclosed in this reference does not necessarily provide electrode location control or easy access to the injury being treated.
SUMMARY OF THE INVENTION
In brief summary, the exemplary embodiment of this invention provides two or more spaced-apart conductive patches with an adhesive boundary extending at least part way about the edges of the patches. The adhesive boundary may comprise a relatively larger adhesive-backed, flexible insulating sheet patch with the relatively smaller conductive patches being affixed therewithin at predetermined proper relative locations (on the one adhesive-coated side). The adhesive-coated border around at least a portion of the electrodes (and preferably completely thereabout) permits the electrodes to be adhesively affixed to treatment locations where electrodes cannot easily be affixed by traditional wrapping techniques. Such an adhesive border forms an occlusive seal with hair, fur and external body tissue surfaces at a time when the treatment site is still relatively clean and dry.
The insulating sheet has at least one aperture therein so as to provide access aperture(s) to the treatment site. To facilitate storage, transport, etc., a release liner is also preferably included and is releasably attached to and covering the otherwise exposed adhesive-backing of the insulating sheet prior to its intended usage. Such a release liner typically is formed of two parts so that the flexible electrode assembly can be slightly flexed to permit easy fingertip access to an edges of the liner thus facilitating its easy removal just prior to the time of intended usage.
Electrical snap-on connection terminals are preferably affixed to each conductive patch and extend backwards through a further aperture in the insulating sheet so as to permit ready electrical connection of a suitable electrical lead from an electrical signal generator or other conventional treatment/diagnostic apparatus. The conductive patches of the assembly are preferably flexible and may be formed from thin metal foil patches pre-laminated to their own thin insulating coating so as to provide added structural strength and to facilitate adhesion to the adhesive-backed insulating patch.
These as well as other objects and advantages of the invention will be better appreicated by carefully reading the following detailed description of the presently preferred exemplary embodiments of this invention taken in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is an exploded perspective view of the various components used in an exemplary embodiment of the adhesively applied multi-element electrode of this invention;
FIG. 2 is a cross-sectional view of the assembled electrode of FIG. 1;
FIGS. 3 and 4 are perspective and cross-sectional views of the FIGS. 1 and 2 embodiment in place with the external body surface of a living subject;
FIGS. 5-9 are perspective views of other exemplary embodiments of the invention, and
FIGS. 10 and 11 are plan views of two further exemplary embodiments of the electrode structure.
DETAILED DESCRIPTION
This invention relates to multiple element electrodes that have predetermined relative sizes and locations relative to an aperture in a common substrate which is applied as a single unit, with the aperture conveniently being used to (1) properly locate the electrodes vis-a-vis the desired treatment site and (2) provide access to the treatment site after affixation of the electrode structure. The electrode elements are constructed of a metal foil or film such as aluminum or a conductive film such as silver paint or carbon compound paint. These elements are affixed to an adhesive coated, thin, clear film such as pvc or mylar or are screened on a thin, clear film with adhesive selectively screened on at the same time. The multi-element electrode is produced with an opening or treatment site window to identify correct placement of the multi-electrode unit over the wound or injury. A release liner is provided on the back of the electrode. A two element example of this multi-element electrode that is useful for treating small skin wounds or burns is shown in FIG. 1. A monophasic or asymmetrical wave may be conventionally applied across the two elements correctly by use of different size electrical connectors or snaps that mate with the corresponding wires from a stimulator.
An important feature of this invention is that one element, identified as the treatment electrode, is maintained at a fixed and optimum distance from the other remote electrode element(s) and at the same time is maintained at a close, but fixed optimum distance from the injury by means of properly locating the treatment site window over the treatment site. Also typically important in such situations is the fact that the surface area of the treatment electrode may be smaller than the surface area of the remote electrode(s) and that a fixed size ratio and relative location is maintained between electrode elements by use of this multi-element electrode. The current density at the injury or treatment site is maintained at a correct higher therapeutic level while the current density under the remote electrode(s) is lower due to the larger surface area of the remote electrode(s). As those in the art will appreciate, when a given current level I passes through a tissue/skin electrode of a given size or area A, the resulting current density (e.g., amperes per square centimeter) is a function of I/A. Thus, for a given current level, the current density can be increased by making the electrode of smaller size or, vice versa, it can be decreased by making the electrode of larger size. And, as will also be appreciated, the distance of a given tissue mass from an electrode (and its relative location with respect to the anode-cathode current path) will also affect the actual current density through the tissue mass (e.g., a wound). In this fashion, the relative sizes and placements of anode and cathode electrodes can be used to determine the effective current density through a wound.
Typically, for repair of bone fractures, an electrode 103 of relatively large area as shown in FIG. 1, is utilized as an anode while a relatively smaller electrode 102 is applied relatively closer to a desired treatment site marker hole 116 (so as to provide an increased physiologically significant electrical current density thereabout) as a cathode electrode, and connected to the signal source (not shown) by lead wire 50. Electrical signals are then conventionally applied to the electrodes so as to achieve desired treatment effects.
It should be noted that in some medical applications the smaller electrode 102 is the anode, and thus the electrode 103 is the cathode. Furthermore, some signal sources e.g. transcutaneous nerve stimulators (TENS), supply biphasic signals to the electrodes, i.e. alternating current or waveforms with both positive and negative components. The present invention can be used with a biphasic signal having the smaller electrode 102 relatively close to the treatment site and the larger electrode 103 at a more remote location. This arrangement insures a higher density at the treatment site and a lower, non-biologically stimulative, signal at the larger electrode 103.
Multi-element electrode 100 is shown in detail at FIGS. 1 and 2. Conductive metal foils 102 and 103 constitute the active electrode surfaces. In the exemplary embodiment, foils 102 and 103 are each actually a very thin (e.g., 0.00035 inch) layer of aluminum foil pre-laminated to a very thin (e.g., 0.00092) layer of polyester film (laminated to the top of structure 102 as seen in FIG. 1) so as to provide added structural strength and to facilitate adhesive affixation to a larger flexible insulating sheet 104 having a treatment site location aperture 116 located centrally (but asymetrically of the electrodes so as to be directly over the intended treatment site located nearer the smaller therapeutic electrode) and having an adhesive coating 104a on its lower side (as seen in FIG. 1). The laminated aluminum foil/ polyester films 102 and 103 may be cut from commerically available material (e.g. part No. 1035 from Lam-A-Shield Incorporated, Cleveland, Ohio). The presently preferred adhesive-backed patch 104 is also cut from commerically available material (e.g. part No. 7350 from 3M Corporation which comprises a thin (e.g., 0.002 inch) insulating sheet of polypropylene with a thin (e.g., 0.0008 inch) coating of acrylic adhesive 104 on one side).
A conventional snap-on type electrical connector comprising mated parts 106a and 106b is attached to a folded-over tab portion 108 of the laminated aluminum foil structure 102. Similar parts 107a and 107b are attached to the fold-over tab portion 109 of foil 103. Since it is folded over (as indicated by arrow 110), a conductive aluminum foil surface is exposed on both the top and bottom of the thus double thickness tab portions 108 and 109 for increased structural support and electrical area connection with the snap-on devices 106a and 106b and 107a and 107b. The snap-on connector parts have a connector projection which extends backwardly (i.e. upwardly in FIG. 1) through apertures 112 and 113 respectively in the insulating patch 104 so as to be readily available for snap-on electrical connection to lead wires 50 and 51.
The flexible electrode assembly of FIGS. 1-2 also includes a releasable liner layer 122 which is normally in place covering the otherwise exposed portions of the adhesive surface 104a until the intended time of usage. Typically, the release liner 122 will include a break 124 so that the entire assembly may be slightly bent at the break to gain finger access to a free edge of the releasable liner 122 and thus facilitate its strippage from the adhesive layer 104a and ready the assembly for adhesive affixation to the desired body surface area.
Release liner 122 is shown as including apertures 126, 128 and 129. Apertures 128 and 129 typically occurs because the liner 122 already may be in place when aperture 116 is cut during manufacturing processes and apertures 128 and 129 permit the assembly of snap-on connectors while the release liner 122 remains in place thus protecting the adhesive layer 104a during manufacturing processes. However it will be appreciated that such apertures are not required since the release liner 122 is typically removed before the remainder of the electrode assembly shown in FIGS. 1-2 is adhesively affixed to a desired body surface site and used.
FIG. 3 depicts the electrodes of FIGS. 1-2 with the releasable liner 122 removed and the remainder of the assembly adhesively secured in place to a desired external body surface 20a of a living subject. Typically, the treatment site 20a should be clean and the connector end of cables 50 and 51 may be snapped onto the snap connectors 106a and 107a to installation of the electrode patches onto the treatment site. Once the protective releasable liner 122 has been removed so as to expose a boundary 130 of adhesive 104a, the assembly is positioned with the treatment aperture 116 over the injury site 20b and pressed firmly thereto so as to assure a good adhesive bond. As shown in the cross-sectional view of FIG. 4, the boundary areas 130 will include an adhesively sealed and occluded area 130a which incorporates any contiguous body hair (or fur) so as to provide a substantially impervious seal between the external surface of living body 20 and the periphery of the conductive electrodes 102 and 103.
As shown in FIG. 5 (having electrodes 202, 203), an electrode patch e.g. 203 can have an aperture 114 extending therethrough for receiving an electrode gel preparation material in the space located between the electrode patch and the skin surface, after the electrode patch is adhesively affixed to the skin.
It should be understood that the present invention may incorporate more than two electrodes, that is a treatment electrode and multiple remote electrodes (see FIGS. 6-8). Further, the electrodes may be arranged in a variety of ways and may be of various shapes and sizes. (see FIGS. 6-9). As shown in FIGS. 6-11, electrodes are denoted by numerals 302, 303; 402, 403; 502, 503; 602, 603; 702, 703; and 802, 803. The flexible insulating substrate is generally shown by the out or most boundary lines and is denoted by reference numerals 704 and 804 in FIGS. 10 and 11 respectively.
When the electrode structure is to be used on horses, it has been experimentally determined that the border area 130 of adhesive available for affixation should probably be at least about 0.75 inch wide to insure good adhesive affixation. FIG. 11 depicts an alternate embodiment without a continuous adhesive border.
As should be appreciated, other patch shapes may utilize the principles of this invention and, for example, an elongated rectangular patch is depicted in FIG. 10. Similarly, for some applications it may not be necessary or even desirable to have a completely continuous adhesive border about the conductive patches. Accordingly, in such cases, the adhesive-backed flexible insulating patch 104 may have a considerably different size and shape from that of the conductive patches as is, for example, depicted at FIG. 11. It will also be appreciated that the adhesive backing might in some cases be applied directly to the periphery or other desired portions of each conductive electrode structure itself. Each conductive patch may also be formed by printing, painting or otherwise placing conductive ink on a suitable substrate. However, in the present exemplary embodiments, aluminum foil is preferred (e.g., it is conceivable that the ions which make an ink conductive might, over time, migrate under influence of the electrical treatment fields away from the printed ink itself thus deteriorating the overall electrode function).
In the present exemplary embodiment the conductive patch 103 may be approximately 3 inches by 1 inch and the treatment electrode 102 about one inch square, while the insulating patch 104 may be approximately 5×51/2 inches in overall dimension. Aperture 116 in the embodiment of FIGS. 1-2 may be approximately 0.688 inch diameter.
It will be understood that the electrode apparatus and method described may also be utilized to achieve conductive coupling to the external skin surfaces of human subjects as well as animals.
Although this invention has been above-described only with respect to a few presently preferred exemplary embodiments, those skilled in the art will recognize that many variations and modifications may be made in these embodiments while yet retaining many of the novel features and advantages of this invention. The following claims are intended to cover all such variations and modifications.

Claims (10)

What is claimed is:
1. A multi-element electrode for making electrical contact to the body surface of a living subject, said electrode comprising:
a first conductive patch having a first area and an electrical connection thereto;
a second conductive patch having a second area and an electrical connection thereto;
an adhesive backed-flexible insulating sheet extending at least part way about the edges of said conductive patches which are positioned at predetermined relative locations on said sheet; and
said adhesive-backed flexible insulating sheet having a treatment location and access aperture extending therethrough at a predetermined asymmetric location relative to said first and second conductive patches.
2. A multi-element electrode as in claim 1 wherein
said conductive patches are affixed on one adhesive-coated side of said sheet, and further including a release liner releasably attached to and covering the otherwise remaining exposed adhesive-backing of said sheet prior to its intended usage.
3. A multi-element electrode as in claim 1 wherein said first patch is a treatment cathode electrode and said second patch is an anode electrode wherein said treatment electrode has a smaller surface area than said anode electrode and wherein said treatment electrode is positioned more closely to said treatment aperture.
4. A multi-element electrode as in claim 2 wherein said electrical connections each comprise an electrical snap-on terminal affixed to one of said conductive patches and extending through further apertures in said sheet towards the other side of said sheet.
5. A multi-element electrode as in claim 4 wherein said conductive patches comprise metal foil patches prelaminated with an insulating coating on the side affixed to said sheet and each patch having a doubled-back tab area at which said terminal is affixed with electrical connections being effected to both the exposed top and bottom metal foil surfaces in the double thickness tab area.
6. A multi-element electrode as in claim 1 wherein at least one patch has at least one gel application aperture extending therethrough.
7. A multi-element electrode for therapeutic or diagnostic applications in medical or veterinary use which may be adhesively affixed to the external body surface of a subject, said electrode comprising:
a plurality of conductive patches for transferring electrical signals to/from the subject;
an adhesive layer extending at least part way about the edges of said conductive patches which are positioned at predetermined relative locations on said layer for holding said conductive patches at predetermined relative locations and in place on the body surface of a subject;
at least one treatment location and access aperture being provided in said adhesive layer at a predetermined location relative to said electrodes which defines the proper location of treatment area and which thus facilitates proper placement over an injury or other treatment site and for access to the site; and
a releasable liner protectively covering the otherwise exposed adhesive surface of said adhesive layer until the liner is removed to permit affixation to said body surface.
8. A multi-element as in claim 7 wherein each patch has a gel aperture extending therethrough to facilitate surface application of electrode preparation material through each gel aperture.
9. A multi-element as in claim 7 or 8 wherein;
said conductive patches each comprise a metal foil patch;
said adhesive layer comprises an adhesive-backed, flexible insulator patch having an area larger than the combined area of said conductive patches;
said metal foil and insulator patches having aligned apertures therethrough;
said metal foil patches being disposed on and within the adhesively-coated side of said insulator patch at predetermined locations relative to said treatment aperture so that there is a predetermined current density at the injury site when the treatment location and access aperture are disposed in a corresponding predetermined relative location thereat.
10. A multi-element as in claim 9 further comprising a snap-on electrical connector terminal affixed to each of said metal foil patches and extending back through an aperture in said insulator patch for access through the other side thereof.
US06/788,215 1985-10-16 1985-10-16 Multi-element electrode Expired - Lifetime US4635641A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/788,215 US4635641A (en) 1985-10-16 1985-10-16 Multi-element electrode

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/788,215 US4635641A (en) 1985-10-16 1985-10-16 Multi-element electrode

Publications (1)

Publication Number Publication Date
US4635641A true US4635641A (en) 1987-01-13

Family

ID=25143801

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/788,215 Expired - Lifetime US4635641A (en) 1985-10-16 1985-10-16 Multi-element electrode

Country Status (1)

Country Link
US (1) US4635641A (en)

Cited By (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4787390A (en) * 1987-04-15 1988-11-29 Scovill Japan Kabushiki Kaisha Electrode sensor
US4865038A (en) * 1986-10-09 1989-09-12 Novametrix Medical Systems, Inc. Sensor appliance for non-invasive monitoring
US5046511A (en) * 1989-11-28 1991-09-10 Empi, Inc. Vaginal electrode with snap-on electrode pad and method for preparing electrode for use
US5254081A (en) * 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
WO1994015527A1 (en) * 1993-01-11 1994-07-21 Jens Axelgaard Medical electrode system
WO1994017853A1 (en) * 1993-02-02 1994-08-18 Becton Dickinson And Company Active drug delivery device, electrode, and method for making same
FR2739015A1 (en) * 1995-09-26 1997-03-28 Prothia Sarl Nerve stimulation with relocatable electrodes
US5645063A (en) * 1995-06-05 1997-07-08 Quinton Instrument Company Skin electrode having multiple conductive center members
FR2746018A1 (en) * 1996-03-15 1997-09-19 Bmr Res & Dev Ltd ELECTRODE ASSEMBLY AND METHOD FOR MANUFACTURING THE SAME
US6148233A (en) * 1997-03-07 2000-11-14 Cardiac Science, Inc. Defibrillation system having segmented electrodes
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
US6782283B2 (en) 2001-09-07 2004-08-24 Robert N. Schmidt Dry penetrating recording device
US6785569B2 (en) 2001-09-07 2004-08-31 Orbital Research Dry physiological recording electrode
US20060173523A1 (en) * 2005-02-01 2006-08-03 Rainey Christopher J Electrode arrangement for applying electrical signals to the skin of an animal
WO2006082384A2 (en) * 2005-02-01 2006-08-10 Wound Solutions Limited Electrode arrangement for applying electrical signals to the skin of an animal
US20070163874A1 (en) * 2001-01-17 2007-07-19 Zuppero Anthony C Electron-Jump Chemical Energy Converter
US7286864B1 (en) 2001-09-07 2007-10-23 Orbital Research, Inc. Dry physiological recording device
US20080161884A1 (en) * 2004-12-23 2008-07-03 Mark Chandler Method and apparatus for treating or preventing a medical condition
US20080306360A1 (en) * 2007-05-24 2008-12-11 Robertson Timothy L Low profile antenna for in body device
US20090076338A1 (en) * 2006-05-02 2009-03-19 Zdeblick Mark J Patient customized therapeutic regimens
US20090082645A1 (en) * 2007-09-25 2009-03-26 Proteus Biomedical, Inc. In-body device with virtual dipole signal amplification
US20090135886A1 (en) * 2007-11-27 2009-05-28 Proteus Biomedical, Inc. Transbody communication systems employing communication channels
US20090227204A1 (en) * 2005-04-28 2009-09-10 Timothy Robertson Pharma-Informatics System
JP2010500076A (en) * 2006-08-07 2010-01-07 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Plaster and radiation system
US20100022836A1 (en) * 2007-03-09 2010-01-28 Olivier Colliou In-body device having a multi-directional transmitter
US20100185055A1 (en) * 2007-02-01 2010-07-22 Timothy Robertson Ingestible event marker systems
US20100312188A1 (en) * 2008-12-15 2010-12-09 Timothy Robertson Body-Associated Receiver and Method
US20100316158A1 (en) * 2006-11-20 2010-12-16 Lawrence Arne Active signal processing personal health signal receivers
US20100318018A1 (en) * 2007-05-25 2010-12-16 Klaus Schonenberger Wound healing electrode set
US20110054265A1 (en) * 2009-04-28 2011-03-03 Hooman Hafezi Highly reliable ingestible event markers and methods for using the same
US20110065983A1 (en) * 2008-08-13 2011-03-17 Hooman Hafezi Ingestible Circuitry
US20110196454A1 (en) * 2008-11-18 2011-08-11 Proteus Biomedical, Inc. Sensing system, device, and method for therapy modulation
US20110196220A1 (en) * 2008-10-22 2011-08-11 Med Storm Innovation As Electrode Assembly for Medical Purposes
US20110212782A1 (en) * 2008-10-14 2011-09-01 Andrew Thompson Method and System for Incorporating Physiologic Data in a Gaming Environment
US8036748B2 (en) 2008-11-13 2011-10-11 Proteus Biomedical, Inc. Ingestible therapy activator system and method
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
WO2014102896A1 (en) * 2012-12-25 2014-07-03 テルモ株式会社 Iontophoresis patch
US20140188200A1 (en) * 2009-10-05 2014-07-03 The Regents Of The University Of California Systems, devices and methods for the treatment of neurological disorders and conditions
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
WO2015079448A1 (en) * 2013-12-01 2015-06-04 Cardiologic Innovations Ltd A patient monitoring system
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US9192313B1 (en) 2013-03-14 2015-11-24 Orbital Research Inc. Dry physiological recording device and method of manufacturing
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
WO2016044341A1 (en) * 2014-09-16 2016-03-24 Enermed, Llc A wound care bandage and method of wound healing
US9364674B2 (en) 2010-11-30 2016-06-14 Ian A. Cook Pulse generator for cranial nerve stimulation
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US20160367434A1 (en) * 2015-06-17 2016-12-22 Mimi Gruber Electroacupuncture enhanced acupressure treatment apparatus and associated electrode assembly
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
EP3131622A4 (en) * 2014-04-14 2017-12-20 Elidah, Inc. Device to treat incontinence
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US10035016B2 (en) 2014-04-14 2018-07-31 Elidah, Inc. Electrical stimulation device
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US10238862B2 (en) 2009-10-05 2019-03-26 The Regents Of The University Of California Extracranial implantable devices, systems and methods for the treatment of medical disorders
US20190091466A1 (en) * 2016-03-01 2019-03-28 Vomaris Innovations, Inc. Bioelectric devices for use on specific areas of the body
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US10639468B2 (en) 2009-10-05 2020-05-05 The Regents Of The University Of California Devices, systems and methods for the treatment of medical disorders
WO2021065580A1 (en) * 2019-10-04 2021-04-08 Nihon Kohden Corporation Body electrode unit
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
WO2023111863A1 (en) * 2021-12-14 2023-06-22 Novocure Gmbh Transducer array with shape that contours to a subject's body and method of determining shape and placement of transducer arrays
WO2023111847A1 (en) * 2021-12-14 2023-06-22 Novocure Gmbh Transducer array with adhesive layer shaped to reduce skin irritation
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2555037A (en) * 1949-06-21 1951-05-29 Jensen Lee Flexible electrode
US3122137A (en) * 1961-10-30 1964-02-25 Erlanger Gustav Device for facilitating iontophoresis treatment of eyes
US3746004A (en) * 1971-06-14 1973-07-17 B Jankelson Disposable electrodes for electrical stimulation of muscles and nerves of the head
US3848600A (en) * 1972-02-03 1974-11-19 Ndm Corp Indifferent electrode in electrosurgical procedures and method of use
US4062364A (en) * 1975-01-21 1977-12-13 Kazumi Masaki Electrode for use in low frequency electronic therapy device
US4082086A (en) * 1976-12-13 1978-04-04 M I Systems, Inc. Ecg monitoring pad
US4367755A (en) * 1979-01-31 1983-01-11 Stimtech, Inc. Stimulating electrode
US4524087A (en) * 1980-01-23 1985-06-18 Minnesota Mining And Manufacturing Company Conductive adhesive and biomedical electrode

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2555037A (en) * 1949-06-21 1951-05-29 Jensen Lee Flexible electrode
US3122137A (en) * 1961-10-30 1964-02-25 Erlanger Gustav Device for facilitating iontophoresis treatment of eyes
US3746004A (en) * 1971-06-14 1973-07-17 B Jankelson Disposable electrodes for electrical stimulation of muscles and nerves of the head
US3848600A (en) * 1972-02-03 1974-11-19 Ndm Corp Indifferent electrode in electrosurgical procedures and method of use
US3848600B1 (en) * 1972-02-03 1988-06-21
US4062364A (en) * 1975-01-21 1977-12-13 Kazumi Masaki Electrode for use in low frequency electronic therapy device
US4082086A (en) * 1976-12-13 1978-04-04 M I Systems, Inc. Ecg monitoring pad
US4367755A (en) * 1979-01-31 1983-01-11 Stimtech, Inc. Stimulating electrode
US4524087A (en) * 1980-01-23 1985-06-18 Minnesota Mining And Manufacturing Company Conductive adhesive and biomedical electrode

Cited By (188)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865038A (en) * 1986-10-09 1989-09-12 Novametrix Medical Systems, Inc. Sensor appliance for non-invasive monitoring
US4787390A (en) * 1987-04-15 1988-11-29 Scovill Japan Kabushiki Kaisha Electrode sensor
US5046511A (en) * 1989-11-28 1991-09-10 Empi, Inc. Vaginal electrode with snap-on electrode pad and method for preparing electrode for use
US5254081A (en) * 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
US5450845A (en) * 1993-01-11 1995-09-19 Axelgaard; Jens Medical electrode system
WO1994015527A1 (en) * 1993-01-11 1994-07-21 Jens Axelgaard Medical electrode system
US5785040A (en) * 1993-01-11 1998-07-28 Axelgaard; Jens Medical electrode system
WO1994017853A1 (en) * 1993-02-02 1994-08-18 Becton Dickinson And Company Active drug delivery device, electrode, and method for making same
US5645063A (en) * 1995-06-05 1997-07-08 Quinton Instrument Company Skin electrode having multiple conductive center members
FR2739015A1 (en) * 1995-09-26 1997-03-28 Prothia Sarl Nerve stimulation with relocatable electrodes
FR2746018A1 (en) * 1996-03-15 1997-09-19 Bmr Res & Dev Ltd ELECTRODE ASSEMBLY AND METHOD FOR MANUFACTURING THE SAME
US6148233A (en) * 1997-03-07 2000-11-14 Cardiac Science, Inc. Defibrillation system having segmented electrodes
US6546285B1 (en) 1997-03-07 2003-04-08 Cardiac Science, Inc. Long term wear electrode for defibrillation system
US9089718B2 (en) 1997-03-07 2015-07-28 Cardiac Science Corporation Defibrillation system
US6609018B2 (en) 2000-07-27 2003-08-19 Ckm Diagnostics, Inc. Electrode array and sensor attachment system for noninvasive nerve location and imaging device
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
US20070163874A1 (en) * 2001-01-17 2007-07-19 Zuppero Anthony C Electron-Jump Chemical Energy Converter
US7286864B1 (en) 2001-09-07 2007-10-23 Orbital Research, Inc. Dry physiological recording device
US6785569B2 (en) 2001-09-07 2004-08-31 Orbital Research Dry physiological recording electrode
US7032301B1 (en) 2001-09-07 2006-04-25 Orbital Research Inc Dry physiological recording electrode
US7032302B1 (en) 2001-09-07 2006-04-25 Orbital Research Inc. Dry physiological recording device
US7489959B1 (en) 2001-09-07 2009-02-10 Orbital Research Inc. Physiological recording device
US6782283B2 (en) 2001-09-07 2004-08-24 Robert N. Schmidt Dry penetrating recording device
US20080161884A1 (en) * 2004-12-23 2008-07-03 Mark Chandler Method and apparatus for treating or preventing a medical condition
WO2006082384A3 (en) * 2005-02-01 2006-12-21 Wound Solutions Ltd Electrode arrangement for applying electrical signals to the skin of an animal
AU2006210702B2 (en) * 2005-02-01 2012-07-26 Oxford Bioelectronics Limited Electrode arrangement for applying electrical signals to the skin of an animal
WO2006082384A2 (en) * 2005-02-01 2006-08-10 Wound Solutions Limited Electrode arrangement for applying electrical signals to the skin of an animal
US7742829B2 (en) 2005-02-01 2010-06-22 Wound Solutions Limited Electrode arrangement for applying electrical signals to the skin of an animal
US20060173523A1 (en) * 2005-02-01 2006-08-03 Rainey Christopher J Electrode arrangement for applying electrical signals to the skin of an animal
US9439582B2 (en) 2005-04-28 2016-09-13 Proteus Digital Health, Inc. Communication system with remote activation
US9681842B2 (en) 2005-04-28 2017-06-20 Proteus Digital Health, Inc. Pharma-informatics system
US10610128B2 (en) 2005-04-28 2020-04-07 Proteus Digital Health, Inc. Pharma-informatics system
US9597010B2 (en) 2005-04-28 2017-03-21 Proteus Digital Health, Inc. Communication system using an implantable device
US20100081894A1 (en) * 2005-04-28 2010-04-01 Proteus Biomedical, Inc. Communication system with partial power source
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9119554B2 (en) 2005-04-28 2015-09-01 Proteus Digital Health, Inc. Pharma-informatics system
US10542909B2 (en) 2005-04-28 2020-01-28 Proteus Digital Health, Inc. Communication system with partial power source
US9649066B2 (en) 2005-04-28 2017-05-16 Proteus Digital Health, Inc. Communication system with partial power source
US9161707B2 (en) 2005-04-28 2015-10-20 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US11476952B2 (en) 2005-04-28 2022-10-18 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US7978064B2 (en) 2005-04-28 2011-07-12 Proteus Biomedical, Inc. Communication system with partial power source
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8674825B2 (en) 2005-04-28 2014-03-18 Proteus Digital Health, Inc. Pharma-informatics system
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US10517507B2 (en) 2005-04-28 2019-12-31 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US20090227204A1 (en) * 2005-04-28 2009-09-10 Timothy Robertson Pharma-Informatics System
US8816847B2 (en) 2005-04-28 2014-08-26 Proteus Digital Health, Inc. Communication system with partial power source
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US20090076338A1 (en) * 2006-05-02 2009-03-19 Zdeblick Mark J Patient customized therapeutic regimens
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US11928614B2 (en) 2006-05-02 2024-03-12 Otsuka Pharmaceutical Co., Ltd. Patient customized therapeutic regimens
JP2010500076A (en) * 2006-08-07 2010-01-07 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Plaster and radiation system
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
US10238604B2 (en) 2006-10-25 2019-03-26 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US11357730B2 (en) 2006-10-25 2022-06-14 Otsuka Pharmaceutical Co., Ltd. Controlled activation ingestible identifier
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US20100316158A1 (en) * 2006-11-20 2010-12-16 Lawrence Arne Active signal processing personal health signal receivers
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9444503B2 (en) 2006-11-20 2016-09-13 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US20100185055A1 (en) * 2007-02-01 2010-07-22 Timothy Robertson Ingestible event marker systems
US10441194B2 (en) 2007-02-01 2019-10-15 Proteus Digital Heal Th, Inc. Ingestible event marker systems
US11464423B2 (en) 2007-02-14 2022-10-11 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US20100022836A1 (en) * 2007-03-09 2010-01-28 Olivier Colliou In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
US20080306360A1 (en) * 2007-05-24 2008-12-11 Robertson Timothy L Low profile antenna for in body device
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US11213672B2 (en) 2007-05-25 2022-01-04 Djo, Llc Wound healing electrode set
US20100318018A1 (en) * 2007-05-25 2010-12-16 Klaus Schonenberger Wound healing electrode set
US10130805B2 (en) 2007-05-25 2018-11-20 Empi, Inc. Wound healing electrode set
US9174042B2 (en) 2007-05-25 2015-11-03 Empi, Inc. Wound healing electrode set
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9433371B2 (en) 2007-09-25 2016-09-06 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US20090082645A1 (en) * 2007-09-25 2009-03-26 Proteus Biomedical, Inc. In-body device with virtual dipole signal amplification
US20090135886A1 (en) * 2007-11-27 2009-05-28 Proteus Biomedical, Inc. Transbody communication systems employing communication channels
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9258035B2 (en) 2008-03-05 2016-02-09 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8810409B2 (en) 2008-03-05 2014-08-19 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8542123B2 (en) 2008-03-05 2013-09-24 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US10682071B2 (en) 2008-07-08 2020-06-16 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US11217342B2 (en) 2008-07-08 2022-01-04 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker data framework
US20110065983A1 (en) * 2008-08-13 2011-03-17 Hooman Hafezi Ingestible Circuitry
US8721540B2 (en) 2008-08-13 2014-05-13 Proteus Digital Health, Inc. Ingestible circuitry
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US20110212782A1 (en) * 2008-10-14 2011-09-01 Andrew Thompson Method and System for Incorporating Physiologic Data in a Gaming Environment
US20110196220A1 (en) * 2008-10-22 2011-08-11 Med Storm Innovation As Electrode Assembly for Medical Purposes
US8036748B2 (en) 2008-11-13 2011-10-11 Proteus Biomedical, Inc. Ingestible therapy activator system and method
US20110196454A1 (en) * 2008-11-18 2011-08-11 Proteus Biomedical, Inc. Sensing system, device, and method for therapy modulation
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8583227B2 (en) 2008-12-11 2013-11-12 Proteus Digital Health, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US20100312188A1 (en) * 2008-12-15 2010-12-09 Timothy Robertson Body-Associated Receiver and Method
US8114021B2 (en) 2008-12-15 2012-02-14 Proteus Biomedical, Inc. Body-associated receiver and method
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9149577B2 (en) 2008-12-15 2015-10-06 Proteus Digital Health, Inc. Body-associated receiver and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US8545436B2 (en) 2008-12-15 2013-10-01 Proteus Digital Health, Inc. Body-associated receiver and method
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US10588544B2 (en) 2009-04-28 2020-03-17 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US20110054265A1 (en) * 2009-04-28 2011-03-03 Hooman Hafezi Highly reliable ingestible event markers and methods for using the same
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US10195435B2 (en) 2009-10-05 2019-02-05 The Regents Of The University Of California Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
US9511223B2 (en) 2009-10-05 2016-12-06 The Regents Of The University Of California Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
US10322283B2 (en) 2009-10-05 2019-06-18 The Regents Of The University Of California Devices, systems and methods for treatment of neuropsychiatric disorders
US9238139B2 (en) 2009-10-05 2016-01-19 The Regents Of The University Of California Devices, systems and methods for treatment of neuropsychiatric disorders
US8958880B2 (en) 2009-10-05 2015-02-17 The Regents Of The University Of California Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
US10639468B2 (en) 2009-10-05 2020-05-05 The Regents Of The University Of California Devices, systems and methods for the treatment of medical disorders
US20140188200A1 (en) * 2009-10-05 2014-07-03 The Regents Of The University Of California Systems, devices and methods for the treatment of neurological disorders and conditions
US10238862B2 (en) 2009-10-05 2019-03-26 The Regents Of The University Of California Extracranial implantable devices, systems and methods for the treatment of medical disorders
US10058704B2 (en) 2009-10-05 2018-08-28 The Regents Of The University Of California Systems, devices and methods for the treatment of neurological disorders and conditions
US9504827B2 (en) * 2009-10-05 2016-11-29 The Regents Of The University Of California Systems, devices and methods for the treatment of neurological disorders and conditions
US9682236B2 (en) 2009-10-05 2017-06-20 The Regents Of The University Of California Devices, systems and methods for treatment of neuropsychiatric disorders
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US9941931B2 (en) 2009-11-04 2018-04-10 Proteus Digital Health, Inc. System for supply chain management
US10305544B2 (en) 2009-11-04 2019-05-28 Proteus Digital Health, Inc. System for supply chain management
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US10376218B2 (en) 2010-02-01 2019-08-13 Proteus Digital Health, Inc. Data gathering system
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US10207093B2 (en) 2010-04-07 2019-02-19 Proteus Digital Health, Inc. Miniature ingestible device
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US11173290B2 (en) 2010-04-07 2021-11-16 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US11504511B2 (en) 2010-11-22 2022-11-22 Otsuka Pharmaceutical Co., Ltd. Ingestible device with pharmaceutical product
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US10016601B2 (en) 2010-11-30 2018-07-10 The Regents Of The University Of California Pulse generator for cranial nerve stimulation
US9364674B2 (en) 2010-11-30 2016-06-14 Ian A. Cook Pulse generator for cranial nerve stimulation
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US11229378B2 (en) 2011-07-11 2022-01-25 Otsuka Pharmaceutical Co., Ltd. Communication system with enhanced partial power source and method of manufacturing same
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
JPWO2014102896A1 (en) * 2012-12-25 2017-01-12 テルモ株式会社 Iontophoresis patch
WO2014102896A1 (en) * 2012-12-25 2014-07-03 テルモ株式会社 Iontophoresis patch
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US9192313B1 (en) 2013-03-14 2015-11-24 Orbital Research Inc. Dry physiological recording device and method of manufacturing
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US11741771B2 (en) 2013-03-15 2023-08-29 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10421658B2 (en) 2013-08-30 2019-09-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10097388B2 (en) 2013-09-20 2018-10-09 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10498572B2 (en) 2013-09-20 2019-12-03 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US11102038B2 (en) 2013-09-20 2021-08-24 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9787511B2 (en) 2013-09-20 2017-10-10 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
WO2015079448A1 (en) * 2013-12-01 2015-06-04 Cardiologic Innovations Ltd A patient monitoring system
US11950615B2 (en) 2014-01-21 2024-04-09 Otsuka Pharmaceutical Co., Ltd. Masticable ingestible product and communication system therefor
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
EP3131622A4 (en) * 2014-04-14 2017-12-20 Elidah, Inc. Device to treat incontinence
US10035016B2 (en) 2014-04-14 2018-07-31 Elidah, Inc. Electrical stimulation device
CN107073261B (en) * 2014-09-16 2021-10-29 嘉伍德实验室有限公司 Wound care bandage and method of wound healing
US9592160B2 (en) 2014-09-16 2017-03-14 Garwood Medical Devices, Llc Wound care bandage and method of wound healing
CN107073261A (en) * 2014-09-16 2017-08-18 嘉伍德医疗设备有限公司 Wound care bandage and wound healing method
EP3194013A4 (en) * 2014-09-16 2018-05-30 Garwood Medical Devices, LLC A wound care bandage and method of wound healing
WO2016044341A1 (en) * 2014-09-16 2016-03-24 Enermed, Llc A wound care bandage and method of wound healing
US20160367434A1 (en) * 2015-06-17 2016-12-22 Mimi Gruber Electroacupuncture enhanced acupressure treatment apparatus and associated electrode assembly
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10980995B2 (en) * 2016-03-01 2021-04-20 Vomaris Innovations, Inc. Bioelectric devices for use on specific areas of the body
US20190091466A1 (en) * 2016-03-01 2019-03-28 Vomaris Innovations, Inc. Bioelectric devices for use on specific areas of the body
US10797758B2 (en) 2016-07-22 2020-10-06 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11793419B2 (en) 2016-10-26 2023-10-24 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
WO2021065580A1 (en) * 2019-10-04 2021-04-08 Nihon Kohden Corporation Body electrode unit
WO2023111863A1 (en) * 2021-12-14 2023-06-22 Novocure Gmbh Transducer array with shape that contours to a subject's body and method of determining shape and placement of transducer arrays
WO2023111847A1 (en) * 2021-12-14 2023-06-22 Novocure Gmbh Transducer array with adhesive layer shaped to reduce skin irritation

Similar Documents

Publication Publication Date Title
US4635641A (en) Multi-element electrode
US4669480A (en) Temperature indicating electrotherapy electrode/coil and method of use
EP0682496B1 (en) Medical electrode system
US4365634A (en) Medical electrode construction
US6418333B1 (en) Floating electrode
US4522211A (en) Medical electrode construction
US4715382A (en) Flat biomedical electrode with reuseable lead wire
US4196737A (en) Transcutaneous electrode construction
US4393584A (en) Method of manufacture of electrode construction
US6600957B2 (en) High-energy disposable medical stimulation electrode
EP1235615B1 (en) Biomedical electrodes and biomedical electrodes for electrostimulation
US4768514A (en) Medical electrode
US4700710A (en) Apertured adhesively applied body electrode apparatus and method
EP0470338A1 (en) Iontophoresis electrode with reservoir and injection site
JP2006517130A (en) Current control electrode
JPH0341190B2 (en)
US4649923A (en) Temperature indicating electrotherapy electrode
US6898465B2 (en) Differential gel body for a medical stimulation electrode
US7245957B2 (en) Snap electrode
US4265253A (en) Skin conducting electrode and electrode assembly
CA2570793C (en) Packaging for medical pads and electrodes
JP3320306B2 (en) Method for manufacturing multipolar bioelectrode
EP0269200A1 (en) Flat biomedical electrode
EP0836864A2 (en) Defibrillator electrode
CN217567139U (en) Vagus nerve stimulator

Legal Events

Date Code Title Description
AS Assignment

Owner name: MURRAY ELECTRONICS ASSOCIATES LIMITED PARTNERSHIP,

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:HOFFMAN, KENT C.;REEL/FRAME:004477/0668

Effective date: 19851009

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

SULP Surcharge for late payment
REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 8

SULP Surcharge for late payment
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS - SMALL BUSINESS (ORIGINAL EVENT CODE: SM02); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 12